{"id":1459,"date":"2021-06-08T14:55:36","date_gmt":"2021-06-08T17:55:36","guid":{"rendered":"https:\/\/petrusraulino.com.br\/?p=1459"},"modified":"2024-11-11T17:20:11","modified_gmt":"2024-11-11T20:20:11","slug":"psychiatric-and-neurological-outcomes-in-236379-covid-19-survivors","status":"publish","type":"post","link":"https:\/\/petrusraulino.com.br\/en\/psychiatric-and-neurological-outcomes-in-236379-covid-19-survivors\/","title":{"rendered":"Psychiatric and neurological outcomes in 236,379 COVID-19 survivors"},"content":{"rendered":"<p><em><strong>By Dr. Petrus Raulino<\/strong><\/em><\/p>\n<p><span style=\"font-weight: 400;\">Since the beginning of the <a href=\"https:\/\/petrusraulino.com.br\/en\/covid-19-and-functional-brain-connectivity\/\">COVID-19<\/a> there is growing concern that survivors may be at greater risk of neurological and psychiatric illnesses.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">An observational study of 62,354 COVID-19 survivors showed an increased risk of mood and anxiety disorders in the first three months after infection. Even among patients without any psychiatric history.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Over time, new research has contributed to science's further understanding of the evolution of COVID-19.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Published research has emerged with large-scale data examining the risks of neurological and psychiatric diagnoses after six months of COVID-19 infection.<\/span><\/p>\n<h2>New study on psychiatric condition after COVID-19<\/h2>\n<p><span style=\"font-weight: 400;\">A recent study carried out at Oxford University and published in the journal <\/span><i><span style=\"font-weight: 400;\">The Lancet Psychiatry<\/span><\/i><span style=\"font-weight: 400;\"> found that one in three people who survive COVID-19 is diagnosed with a neurological or psychiatric condition six months after being infected.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">To reach this conclusion, the study analyzed the health records of more than 230,000 people with confirmed COVID-19 in 62 healthcare organizations, mainly in the USA.<\/span><\/p>\n<h2>Study results<\/h2>\n<p><span style=\"font-weight: 400;\">Overall, the estimated incidence of diagnosis of a neurological or psychiatric disorder after COVID-19 infection was 34%. For 13% of these people, it was the first recorded neurological or psychiatric diagnosis.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The most common diagnoses after COVID-19 were anxiety disorders (occurring in 17% of patients), mood disorders (14%), substance use disorders (7%) and insomnia (5%).\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The incidence of neurological outcomes was lower, including 0.6% for cerebral hemorrhage, 2.1% for ischemic stroke and 0.7% for dementia.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">It is worth noting that these incidences were even higher in patients who required hospitalization and markedly higher in those who required ICU admission or developed encephalopathy.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Many people wonder how a respiratory illness can cause psychiatric or neurological effects, and the answer to this question is still unclear as to the exact pathophysiological mechanism.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">However, there are several hypotheses for the potential mechanisms that cause the association between COVID-19 and psychiatric disorders and\/or neurological damage. These include viral invasion of the central nervous system, hypercoagulable states and neural effects of the immune response.\u00a0<\/span><\/p>\n<h2>Conclusion<\/h2>\n<p><span style=\"font-weight: 400;\">Unfortunately, many of <\/span><span style=\"font-weight: 400;\">psychiatric disorders<\/span><span style=\"font-weight: 400;\"> identified by COVID-19 research tend to be chronic or recurrent. Therefore, we can anticipate that the burden of COVID-19 could be with us for many years to come.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">On the other hand, research continues and could also provide us with valuable information on how to deal with or overcome the burden of COVID-19.<\/span><\/p>\n<p>&nbsp;<\/p>\n<h4><strong>References<\/strong><\/h4>\n<p><span style=\"font-weight: 400;\">Lee, M. H., Perl, D. P., Nair, G., Li, W., Maric, D., Murray, H., ... &amp; Nath, A. (2021). Microvascular injury in the brains of patients with Covid-19.\u00a0<\/span><i><span style=\"font-weight: 400;\">New England Journal of Medicine<\/span><\/i><span style=\"font-weight: 400;\">,\u00a0<\/span><i><span style=\"font-weight: 400;\">384<\/span><\/i><span style=\"font-weight: 400;\">(5), 481-483.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Taquet, M., Luciano, S., Geddes, J. R., &amp; Harrison, P. J. (2021). Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA.\u00a0<\/span><i><span style=\"font-weight: 400;\">The Lancet Psychiatry<\/span><\/i><span style=\"font-weight: 400;\">,\u00a0<\/span><i><span style=\"font-weight: 400;\">8<\/span><\/i><span style=\"font-weight: 400;\">(2), 130-140.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Taquet, M., Geddes, J. R., Husain, M., &amp; Harrison, P. J. (2021). Six-Month neurological and psychiatric outcomes in 236,379 survivors of COVID-19. <\/span><i><span style=\"font-weight: 400;\">The Lancet Psychiatry<\/span><\/i><span style=\"font-weight: 400;\">, April 6, published on-line.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Kreye, J., Reincke, S. M., &amp; Pr\u00fcss, H. (2020). Do cross-reactive antibodies cause neuropathology in COVID-19?\u00a0<\/span><i><span style=\"font-weight: 400;\">Nature Reviews Immunology<\/span><\/i><span style=\"font-weight: 400;\">,\u00a0<\/span><i><span style=\"font-weight: 400;\">20<\/span><\/i><span style=\"font-weight: 400;\">(11), 645-646.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Meinhardt, J., Radke, J., Dittmayer, C., Franz, J., Thomas, C., Mothes, R., ... &amp; Heppner, F. L. (2021). Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19.\u00a0<\/span><i><span style=\"font-weight: 400;\">Nature neuroscience<\/span><\/i><span style=\"font-weight: 400;\">,\u00a0<\/span><i><span style=\"font-weight: 400;\">24<\/span><\/i><span style=\"font-weight: 400;\">(2), 168-175.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Rhea, E. M., Logsdon, A. F., Hansen, K. M., Williams, L. M., Reed, M. J., Baumann, K. K., ... &amp; Erickson, M. A. (2021). The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice.\u00a0<\/span><i><span style=\"font-weight: 400;\">Nature neuroscience<\/span><\/i><span style=\"font-weight: 400;\">,\u00a0<\/span><i><span style=\"font-weight: 400;\">24<\/span><\/i><span style=\"font-weight: 400;\">(3), 368-378.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Panigada, M., Bottino, N., Tagliabue, P., Grasselli, G., Novembrino, C., Chantarangkul, V., ... &amp; Tripodi, A. (2020). Hypercoagulability of COVID<\/span><span style=\"font-weight: 400;\">?<\/span><span style=\"font-weight: 400;\">19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis.\u00a0<\/span><i><span style=\"font-weight: 400;\">Journal of Thrombosis and Haemostasis<\/span><\/i><span style=\"font-weight: 400;\">,\u00a0<\/span><i><span style=\"font-weight: 400;\">18<\/span><\/i><span style=\"font-weight: 400;\">(7), 1738-1742.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>By Dr. Petrus Raulino Since the beginning of the COVID-19 pandemic, there has been growing concern that survivors may be at greater risk of neurological and psychiatric disorders. An observational study of 62,354 COVID-19 survivors showed an increased risk of mood and anxiety disorders in the first three months after infection. Even among patients [...]<\/p>","protected":false},"author":4,"featured_media":1479,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_joinchat":[],"footnotes":""},"categories":[127,109,115,121,117],"tags":[],"class_list":["post-1459","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biologia-e-saude-mental","category-curiosidades","category-informativo","category-saude-mental","category-transtornos-psicologicos"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.7 (Yoast SEO v26.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Desfechos psiqui\u00e1tricos\/neurol\u00f3gicos em sobreviventes de COVID<\/title>\n<meta name=\"description\" content=\"Desde o in\u00edcio da pandemia \u00e9 crescente a preocupa\u00e7\u00e3o de que os sobreviventes possam ter risco de doen\u00e7as neurol\u00f3gicas e psiqui\u00e1tricas.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/petrusraulino.com.br\/en\/psychiatric-and-neurological-outcomes-in-236379-covid-19-survivors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Desfechos psiqui\u00e1tricos e neurol\u00f3gicos em 236.379 sobreviventes de COVID-19\" \/>\n<meta property=\"og:description\" content=\"Desde o in\u00edcio da pandemia \u00e9 crescente a preocupa\u00e7\u00e3o de que os sobreviventes possam ter risco de doen\u00e7as neurol\u00f3gicas e psiqui\u00e1tricas.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/petrusraulino.com.br\/en\/psychiatric-and-neurological-outcomes-in-236379-covid-19-survivors\/\" \/>\n<meta property=\"og:site_name\" content=\"Dr. Petrus Raulino\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/drpetrusraulinopsiquiatriaclinica\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-08T17:55:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-11T20:20:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/petrusraulino.com.br\/wp-content\/uploads\/2021\/06\/desfechos.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1540\" \/>\n\t<meta property=\"og:image:height\" content=\"860\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Petrus Raulino\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Petrus Raulino\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Psychiatric\/neurological outcomes in COVID survivors","description":"Since the beginning of the pandemic, there has been growing concern that survivors may be at risk of neurological and psychiatric illnesses.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/petrusraulino.com.br\/en\/psychiatric-and-neurological-outcomes-in-236379-covid-19-survivors\/","og_locale":"en_US","og_type":"article","og_title":"Desfechos psiqui\u00e1tricos e neurol\u00f3gicos em 236.379 sobreviventes de COVID-19","og_description":"Desde o in\u00edcio da pandemia \u00e9 crescente a preocupa\u00e7\u00e3o de que os sobreviventes possam ter risco de doen\u00e7as neurol\u00f3gicas e psiqui\u00e1tricas.","og_url":"https:\/\/petrusraulino.com.br\/en\/psychiatric-and-neurological-outcomes-in-236379-covid-19-survivors\/","og_site_name":"Dr. Petrus Raulino","article_publisher":"https:\/\/www.facebook.com\/drpetrusraulinopsiquiatriaclinica","article_published_time":"2021-06-08T17:55:36+00:00","article_modified_time":"2024-11-11T20:20:11+00:00","og_image":[{"width":1540,"height":860,"url":"https:\/\/petrusraulino.com.br\/wp-content\/uploads\/2021\/06\/desfechos.jpg","type":"image\/jpeg"}],"author":"Dr. Petrus Raulino","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Petrus Raulino","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[]}},"_links":{"self":[{"href":"https:\/\/petrusraulino.com.br\/en\/wp-json\/wp\/v2\/posts\/1459","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/petrusraulino.com.br\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/petrusraulino.com.br\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/petrusraulino.com.br\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/petrusraulino.com.br\/en\/wp-json\/wp\/v2\/comments?post=1459"}],"version-history":[{"count":1,"href":"https:\/\/petrusraulino.com.br\/en\/wp-json\/wp\/v2\/posts\/1459\/revisions"}],"predecessor-version":[{"id":45253,"href":"https:\/\/petrusraulino.com.br\/en\/wp-json\/wp\/v2\/posts\/1459\/revisions\/45253"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/petrusraulino.com.br\/en\/wp-json\/wp\/v2\/media\/1479"}],"wp:attachment":[{"href":"https:\/\/petrusraulino.com.br\/en\/wp-json\/wp\/v2\/media?parent=1459"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/petrusraulino.com.br\/en\/wp-json\/wp\/v2\/categories?post=1459"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/petrusraulino.com.br\/en\/wp-json\/wp\/v2\/tags?post=1459"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}